A Rras2-BMPR2 feedback loop sustains osteogenesis and represents a therapeutic target for osteoporosis

Renlei Yang1, Mingying Li2,3, Qi Xue4

  • 1Department of Plastic Surgery, Affiliated Friendship Plastic Surgery Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China. yang_renlei@126.com.

Insights

Ras-related protein 2 (Rras2) mutations cause Noonan syndrome. Rras2 deficiency in mice leads to osteopenia, but restoring Rras2 rescues bone loss, identifying a key pathway for bone health.

Area of Science:

  • Molecular biology
  • Genetics
  • Bone biology

Background:

  • Ras-related protein 2 (Rras2) mutations are associated with Noonan syndrome, a genetic disorder.
  • The precise function of Rras2 in maintaining bone homeostasis is not well understood.
  • Existing knowledge gaps hinder the development of targeted clinical interventions for bone-related disorders.

Purpose of the Study:

  • To elucidate the role of Rras2 in bone homeostasis and osteogenesis.
  • To investigate the molecular mechanisms by which Rras2 influences bone health.
  • To explore the therapeutic potential of Rras2 restoration in bone loss conditions.

Main Methods:

  • Utilized a mouse model deficient in Rras2 to study bone phenotypes.
  • Assessed osteogenic differentiation of bone marrow mesenchymal stem cells.
  • Investigated the molecular interaction between Rras2, BMPR2, and Smurf1.
  • Employed adeno-associated virus 9 (AAV9) for Rras2 gene delivery in vivo.

Main Results:

  • Rras2 deficiency in mice resulted in osteopenia, reduced bone strength, and impaired osteogenesis.
  • Rras2 was found to promote osteogenic differentiation and bone regeneration.
  • Rras2 stabilizes BMPR2 by inhibiting Smurf1-mediated degradation, creating a positive feedback loop with BMP signaling.
  • Restoration of Rras2 expression using AAV9 effectively rescued bone loss in osteoporotic mice.

Conclusions:

  • A critical Rras2-BMPR2 positive feedback loop regulates bone homeostasis.
  • Rras2 plays a vital role in osteoblast differentiation and bone regeneration.
  • Targeting the Rras2 pathway offers a potential therapeutic strategy for osteoporosis and Noonan syndrome.

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...